超极化激活环核苷酸门控2(HCN2)离子通道驱动糖尿病神经病变小鼠模型中的疼痛
研究利用1型和2型糖尿病小鼠模型,探讨超极化激活环核苷酸门控2(HCN2)离子通道在糖尿病疼痛中的作用。阻断或基因敲除小伤害性神经元中的HCN2通道可抑制糖尿病相关机械性异常性疼痛,并阻止脊髓二级神经元激活。疼痛性糖尿病动物模型中感觉神经元内环磷酸腺苷(cAMP)升高,作者提出cAMP增加通过促进HCN2激活驱动疼痛,HCN2可能是治疗疼痛性糖尿病神经病变的镇痛靶点。
要点
- 阻断或基因敲除HCN2通道可抑制糖尿病小鼠的机械性异常性疼痛。
- HCN2通道阻断可阻止糖尿病小鼠脊髓二级神经元的激活。
- 疼痛性糖尿病动物模型感觉神经元内cAMP升高,可能通过HCN2驱动疼痛。
核心结论
- 研究结果提示HCN2可能是治疗疼痛性糖尿病神经病变的镇痛靶点。
研究设计与样本
- 研究使用1型和2型糖尿病小鼠模型,通过阻断或基因敲除HCN2通道进行观察。
主要发现
- 在小鼠中,阻断或基因敲除小伤害性神经元中的HCN2通道可抑制糖尿病相关机械性异常性疼痛。
- 阻断或基因敲除HCN2通道可阻止小鼠脊髓二级神经元的神经元激活。
- 在疼痛性糖尿病动物模型中,感觉神经元内环磷酸腺苷(cAMP)升高。
关键数值与推荐
- 原文未报告具体数值标准。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetic patients frequently suffer from continuous pain that is poorly treated by currently available analgesics. We used mouse models of type 1 and type 2 diabetes to investigate a possible role for the hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels as drivers of diabetic pain. Blocking or genetically deleting HCN2 channels in small nociceptive neurons suppressed diabetes-associated mechanical allodynia and prevented neuronal activation of second-order neurons in the spinal cord in mice. In addition, we found that intracellular cyclic adenosine monophosphate (cAMP), a positive HCN2 modulator, is increased in somatosensory neurons in an animal model of painful diabetes. We propose that the increased intracellular cAMP drives diabetes-associated pain by facilitating HCN2 activation and consequently promoting repetitive firing in primary nociceptive nerve fibers. Our results suggest that HCN2 may be an analgesic target in the treatment of painful diabetic neuropathy.
引用
- Tsantoulas C, Laínez S, Wong S, et al. Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy. Sci Transl Med. 2017. PMID: 28954930. doi:10.1126/scitranslmed.aam6072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。